The evolution of antihypertensive therapy: An overview of four decades of experience
Data up to Jan 2025
Total Citations Per Year
Abstract
References (188)
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
1987 • 4,763 citations
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 • 3,818 citations
The Natural History of Congestive Heart Failure: The Framingham Study
1971 • 3,350 citations
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
1984 • 3,130 citations
A STUDY OF THE ADRENOTROPIC RECEPTORS
1948 • 2,856 citations
The pharmacological basis of therapeutics
1981 • 2,853 citations
STUDIES ON EXPERIMENTAL HYPERTENSION
1934 • 2,092 citations
MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2
1985 • 1,482 citations
Effects Morbidity of Treatment on in Hypertension
1970 • 1,278 citations
Five-Year Findings of the Hypertension Detection and Follow-up Program
1979 • 1,212 citations
The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
1988 • 1,091 citations
Epidemiology of coronary heart disease: The Framingham study
1984 • 1,072 citations
Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem
1980 • 865 citations
Medicine and the Law
1969 • 849 citations
The Heart in Hypertension
1992 • 774 citations
Left Ventricular Hypertrophy by Electrocardiogram
1969 • 762 citations
Propranolol Inhibition of Renin Secretion
1972 • 729 citations
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
1985 • 726 citations
BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE
1987 • 660 citations
A placebo-controlled trial of captopril in refractory chronic congestive heart failure
1983 • 562 citations
Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction
1986 • 539 citations
The Australian therapeutic trial in mild hypertension.
1984 • 528 citations
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
1981 • 511 citations
A Specific Sympathomimetic Ergone in Adrenergic Nerve Fibres (Sympathin) and its Relations to Adrenaline and Nor‐Adrenaline
1946 • 502 citations
Overview of Results of Randomized Clinical Trials in Heart Disease
1988 • 501 citations
Salt, volume and the prevention of hypertension.
1976 • 489 citations
Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY Trial
1987 • 477 citations
The pharmacological basis of therapeutics. 6th ed
1981 • 470 citations
Treatment of Hypertension with Propranolol
1969 • 426 citations
Use of Propranolol (Inderal) in Treatment of Hypertension
1964 • 407 citations
Gating currents and charge movements in excitable membranes
2006 • 405 citations
The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.
1987 • 391 citations
Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure
1980 • 380 citations
Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol.
1958 • 373 citations
Converting-Enzyme Inhibitors in the Treatment of Hypertension
1988 • 362 citations
Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
1985 • 348 citations
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
1986 • 342 citations
Pharmacology of Antihypertensive Drugs.
1980 • 330 citations
Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors
1960 • 307 citations
Pathophysiologic assessment of hypertensive heart disease with echocardiography
1977 • 294 citations
Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic Blockade
1972 • 274 citations
The Paradox of Beta-Adrenergic Blockade in Hypertension
1968 • 265 citations
Vasodilator Drugs in the Treatment of Hypertension
1974 • 263 citations
Surgery's Relevance to an Understanding of Basic Biology
1967 • 258 citations
Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine
1960 • 254 citations
Potent new inhibitors of human renin
1982 • 239 citations
Hyperdynamic ß-Adrenergic Circulatory State
1969 • 236 citations
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
1983 • 234 citations
THE AUSTRALIAN THERAPEUTIC TRIAL IN MILD HYPERTENSION
1980 • 234 citations
β-Adrenoceptor Antagonists: New Drugs and New Indications
1981 • 231 citations
Intermittent claudication — its natural course
1976 • 215 citations
THE PHARMACOLOGY OF ADRENERGIC BLOCKADE
1949 • 203 citations
Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in Hypertension
1972 • 200 citations
False Adrenergic Transmitters
1968 • 197 citations
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management
1973 • 190 citations
Studies on the Control of Hypertension by Hyphex
1953 • 190 citations
Cardiovascular Morbidity in Relation to Change in Blood Pressure and Serum Cholesterol Levels in Treated Hypertension
1987 • 188 citations
Minoxidil — An Alternative to Nephrectomy for Refractory Hypertension
1973 • 184 citations
THE METHONIUM COMPOUNDS
1952 • 183 citations
Nadolol
1980 • 183 citations
Adrenergic Neurone Blocking Agents
1965 • 178 citations
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness
1969 • 175 citations
Six-Year Follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction
1985 • 173 citations
Hyperdynamic Beta-Adrenergic Circulatory State
1966 • 170 citations
Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril
1982 • 169 citations
The Effects of Antihypertensive Agents on Serum Lipids and Lipoproteins
1988 • 169 citations
Preganglionic sympathetic activity in normal and in reserpine‐treated cats
1960 • 169 citations
Dependence of Arterial Pressure on Intravascular Volume in Treated Hypertensive Patients
1972 • 161 citations
Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)
1967 • 154 citations
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
1960 • 150 citations
Unrecognized myocardial infarction and hypertension: The Framingham Study
1985 • 149 citations
The pharmacology of adrenergic blockade.
1949 • 144 citations
Prazosin: the first-dose phenomenon.
1976 • 143 citations
Central nervous system effects of four β-adrenergic receptor blocking agents
1966 • 130 citations
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
1986 • 129 citations
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
1988 • 120 citations
Effect of vasodilators on survival in chronic congestive heart failure
1985 • 120 citations
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats
1982 • 118 citations
Cardiovascular effects of verapamil in patients with essential hypertension.
1987 • 117 citations
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
1987 • 116 citations
Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
1987 • 115 citations
Plasma Volume Expansion Resulting from Interference with Adrenergic Function in Normal Man
1968 • 111 citations
Hypertension and Sudden Death
1989 • 108 citations
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the multiple risk factor intervention trial
1986 • 107 citations
Central hypotensive effect of α-methyldopa
1968 • 103 citations
Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
1977 • 101 citations
Hemodynamic comparison of agents useful in hypertensive emergencies
1973 • 100 citations
Persistence of Reduction in Blood Pressure and Mortality of Participants in the Hypertension Detection and Follow-up Program
1988 • 100 citations
Antihypertensive Agents.
1968 • 98 citations
Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist Activity
1983 • 97 citations
Effects of diltiazem on serum lipids, exercise performance and blood pressure: Randomized, double-blind, placebo-controlled evaluation for systemic hypertension
1985 • 96 citations
Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.
1982 • 96 citations
Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline
1971 • 95 citations
THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. III. HEXAMETHONIUM 123
1953 • 92 citations
Inhibition of Angiotensin-Converting Enzyme for Diagnosis of Renal-Artery Stenosis
1978 • 92 citations
Alpha-Adrenergic Receptor Blockade with Prazosin
1982 • 90 citations
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension
1985 • 90 citations
Clonidine: A new antihypertensive agent
1971 • 87 citations
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.
1984 • 84 citations
Effect of Methyldopa on Plasma Renin Activity in Man
1969 • 82 citations
ON THE NATURE OF THE PRESSOR ACTION OF RENIN
1939 • 79 citations
Hydralazine and Plasma Renin Activity
1968 • 79 citations
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
1986 • 75 citations
Circulatory effects of sympathomimetic amines
1962 • 73 citations
Metoprolol
1977 • 71 citations
Suddent cardic death— Management of the patient at risk
1980 • 70 citations
The use of propranolol in the treatment of hypertension.
1973 • 70 citations
Captopril in patients with type II diabetes and renal insufficiency: Systemic and renal hemodynamic alterations
1988 • 70 citations
Circulatory Effects of Guanethidine
1960 • 70 citations
Platelet α2-Adrenergic Receptors in Treated and Untreated Essential Hypertension
1983 • 67 citations
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension
1989 • 65 citations
Clinical pharmacology of slow channel blocking agents
1982 • 61 citations
Intravenous labetalol in the management of severe hypertension and hypertensive emergencies
1984 • 60 citations
Hemodynamic Effects of Methyldopa (Aldomet®) at Rest and during Exercise in Patients with Arterial Hypertension
1962 • 59 citations
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.
1975 • 57 citations
Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory.
1977 • 56 citations
Minoxidil-Induced Hypertrichosis
1977 • 55 citations
Serum lipoprotein changes during atenolol treatment of essential hypertension
1981 • 55 citations
Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.
1988 • 55 citations
Myocardial Ischemia
1977 • 52 citations
Effect of drug therapy on survival in chronic congestive heart failure
1988 • 51 citations
Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: Studies in essential hypertensive man and the spontaneously hypertensive rat
1987 • 51 citations
Autonomic Nervous System and Benign Essential Hypertension in Man
1974 • 51 citations
The first Irvine H. Page lecture The mosaic of hypertension
1988 • 51 citations
A Comparison of the Cardiovascular Effects of Sodium Nitroprusside and Trimethaphan
1977 • 50 citations
Hemodynamic factors in the pathogenesis and maintenance of hypertension.
1982 • 50 citations
CARDIOVASCULAR AND RENAL HEMODYNAMIC RESPONSE TO RESERPINE (SERPASIL), AND CLINICAL RESULTS OF USING THIS AGENT FOR THE TREATMENT OF HYPERTENSION
1954 • 50 citations
Current concepts in treatment of hypertensive emergencies
1986 • 49 citations
The effects of alpha-methyldopa on renal function in hypertensive patients
1968 • 49 citations
Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response.
1951 • 46 citations
Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension.
1982 • 44 citations
Disparate Effects of Methyldopa and Clonidine on Cardiac Mass and Haemodynamics in Rats
1980 • 43 citations
Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations
1979 • 42 citations
Renal Hemodynamic Consequences of Angiotensin-Converting Enzyme Inhibition in Congestive Heart Failure
1989 • 42 citations
Angiotensin converting enzyme inhibitors. Present and future.
1989 • 41 citations
Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
1982 • 39 citations
Occult Systemic Lupus Erythematosus in Elderly Men
1983 • 38 citations
Relationships Between the Release and Tissue Depletion of Norepinephrine from the Heart by Guanethidine and Reserpine
1963 • 38 citations
A Double Blind Control Study of Antihypertensive Agents
1960 • 38 citations
A highly potent and long-acting oral inhibitor of human renin.
1988 • 36 citations
Pathophysiology: Altered Regulatory Mechanisms in Disease.
1985 • 36 citations
EFFECT OF HYPOTENSION-PRODUCING DRUGS ON THE RENAL CIRCULATION
1952 • 35 citations
Goals of Antihypertensive Therapy
1989 • 35 citations
Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients
1982 • 34 citations
Effects of prazosin in patients with hypertension
1976 • 34 citations
The central action of clonidine and its antagonism
1972 • 33 citations
Importance of Left Ventricular Mass as a Predictor of Cardiovascular Morbidity in Hypertension
1989 • 33 citations
Low-Dose Captopril
1982 • 30 citations
Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass
1989 • 28 citations
Analysis of the Acute Circulatory Effects of Guanethidine and Bretylium
1962 • 27 citations
The acute hemodynamic effects of α-methyldopa in man
1962 • 27 citations
Cardiovascular and Renal Responses to the Combination of Hexamethonium and 1-Hydrazinophthalazine (Apresoline®) in Hypertensive Subjects1
1955 • 26 citations
Inhibition of Adrenergic Function in the Treatment of Hypertension
1974 • 25 citations
Protective Action of Calcium Channel Antagonists in Atherogenesis and Experimental Vascular Injury
1989 • 25 citations
Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience.
1986 • 24 citations
Captoril
1982 • 24 citations
Diuretics in Hypertension
1987 • 23 citations
Double Blind Control Study of Antihypertensive Agents
1962 • 23 citations
Hypertension update : mechanisms epidemiology evaluation management
1980 • 23 citations
The effects of antihypertensive agents on serum lipids and lipoproteins
1988 • 23 citations
Renal response to angiotensin-converting enzyme inhibition
1982 • 22 citations
The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol.
1986 • 21 citations
Beta-adrenergic blocking therapy in hypertension: selection of patients.
1970 • 21 citations
Pheochromocytoma — Recognition and management
1979 • 21 citations
Effects of Calcium Channel Antagonists and Other Antihypertensive Drugs on Atherogenesis
1987 • 20 citations
Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension
1982 • 19 citations
Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
1989 • 18 citations
Renal function in patients with essential hypertension receiving nadolol.
1980 • 18 citations
The heart in hypertension: unresolved conceptual challenges. Special lecture.
1988 • 18 citations
Hemodynamic effects of intravenous labetalol in essential hypertension
1983 • 17 citations
Calcium Antagonists in Patients with Cardiovascular Disease
1985 • 16 citations
Treating hypertension: A review of clinical trials
1986 • 15 citations
THE L. E. CELL AS A MANIFESTATION OF DELAYED HYDRALAZINE INTOXICATION
1956 • 15 citations
Minoxidil-Induced Systemic Lupus Erythematosus
1987 • 15 citations
Hyperdynamic Beta-Adrenergic
1970 • 14 citations
Effect of Clonidine Therapy on Renal Hemodynamics in Renal Transplant Hypertension
1984 • 14 citations
Hypertension and Angina Pectoris
1978 • 14 citations
Arterial vasodilators, cardiac volume load, and cardiac hypertrophy in normotensive rats
1989 • 13 citations
The phase diagram of cetomacrogol 1000—water–benzaldehyde in the presence of gallate antioxidants
1971 • 11 citations
Metoprolol: A Review of its Pharmacological Properties and Therapeutic Efficacy in Hypertension
1979 • 10 citations
Introduction
1985 • 10 citations
Reduction of the Hypotensive Effect of Clonidine and α-Methyldopa by Various Psychotropic Drugs
1976 • 10 citations
Renal Failure Associated With Captopril
1983 • 9 citations
Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension
1982 • 8 citations
Diuretics as antihypertensive drugs.
1988 • 6 citations
Calcium antagonists variably change cardiovascular mass and improve function in rats
1990 • 5 citations
Hospital Junior Staff
1965 • 5 citations
PATHOPHYSIOLOGY : altered regulatory mechanisms in disease, 3rd ed.
1984 • 2 citations